The present study describes the toxic-agent profile documented among patients presenting with acute poisoning to a single emergency department over six years. The most frequently recorded categories included benzodiazepines; methanol; antidepressants; 4-aminophenol derivatives (e.g., acetaminophen); NSAIDs; anticoagulant-related categories; non-opioid analgesics, antipyretic and antirheumatic drugs; narcotics/hallucinogens; and methadone. The predominance of pharmaceutical agents is broadly consistent with evidence from Iranian hospital-based studies and international emergency department reports, although the relative contribution of individual agents varies across settings (
9,
10).
Benzodiazepines were the most frequently recorded toxic-agent category in this cohort (11.0%). This finding is consistent with contemporary emergency department and toxicology surveillance data showing that psychoactive medications are frequently involved in poisoning presentations (
11-
13). The prominence of benzodiazepines may reflect their widespread availability and clinical use; however, because the present study did not systematically record poisoning intent or co-ingestion at the patient level, the mechanisms underlying their frequency cannot be established from these data.
Antidepressants, 4-aminophenol derivatives (primarily acetaminophen/paracetamol), NSAIDs, and other non-opioid analgesics were also among the more frequently recorded categories. Similar pharmaceutical profiles have been reported in contemporary emergency department studies (
11,
12). These comparisons should be interpreted cautiously because differences in case definitions, healthcare settings, coding practices, and the availability of denominator data may influence the observed distribution of toxic agents.
Methanol accounted for 9.3% of the included cases and was the second most frequently recorded toxic-agent category. Methanol poisoning has been an important toxicological concern in Iran, including during the COVID-19 pandemic, when a large outbreak was documented and attributed to multiple interacting social and policy factors (
14). In the present study, however, the data are insufficient to determine the source of exposure or establish whether the observed frequency reflects an outbreak, local availability, or other contextual factors. The finding should therefore be interpreted as a feature of this hospital-based cohort rather than as evidence of a broader regional trend.
Methadone and other narcotic/hallucinogenic categories were also represented among the included cases. International surveillance demonstrates substantial geographic variation in the substances involved in opioid-related poisoning, reflecting differences in drug availability and patterns of use (
13,
15). In the present study, the available descriptive data do not allow conclusions regarding prescribing practices, opioid substitution therapy, or community-level exposure patterns.
Taken together, the findings indicate that pharmaceutical agents accounted for many of the poisoning categories recorded in this emergency department cohort, with methanol also representing a notable category. These observations may inform local clinical preparedness, medication safety initiatives, and toxicological surveillance. However, they should not be interpreted as estimates of poisoning patterns in Tehran or Iran as a whole because the study was conducted at a single hospital and lacked population or emergency department denominators.
A larger proportion of the included cases was recorded between June and September. Similar seasonal variation has been described in some hospital-based poisoning studies (
16). However, because the present study lacked monthly emergency department denominators and did not perform inferential analyses, we cannot determine whether the observed distribution represents a true seasonal increase in poisoning incidence. Possible explanations, including changes in outdoor activity, occupational exposure, or environmental conditions, remain hypotheses that require confirmation in studies with appropriate denominators and exposure data.
Fewer poisoning cases were recorded during 2020 and 2021 than during the other study years. This observation coincided with the COVID-19 pandemic, during which substantial changes in emergency department utilization were reported internationally (
17,
18). However, without annual emergency department denominators and population-level exposure data, the present study cannot determine whether the lower number of recorded cases reflects a true reduction in poisoning, altered healthcare-seeking behavior, changes in exposure, or a combination of these factors. Reports of changes in poisoning exposures during the pandemic further support the need for cautious interpretation (
19).
Young adults represented the largest age group in this cohort, with the highest frequency among individuals aged 20 - 29 years, followed by those aged 15 - 19 years. Similar age distributions have been reported in hospital-based poisoning studies (
9,
10,
20). The concentration of cases in younger age groups highlights the potential value of prevention strategies focused on medication safety, substance-use education, and early recognition of poisoning; nevertheless, the present descriptive design cannot establish specific behavioral or causal mechanisms.
5.1. Limitations
Several limitations warrant consideration. First, the study was conducted at a single hospital and included relatively few poisoning cases, limiting generalizability to other hospitals or the wider population. Second, the retrospective design depended on the completeness and accuracy of existing medical records, and the findings may therefore be affected by missing information and selection bias. Third, total emergency department visits and population denominators were unavailable, precluding calculation of annual or monthly incidence rates and limiting interpretation of temporal and seasonal differences. Fourth, poisoning intent and detailed patient-level co-ingestion information were unavailable in the extracted dataset, and outcomes after transfer to other hospitals could not be independently verified. Finally, the study retained toxic-agent categories as recorded in the source records; exact patient-level ICD-10-CM code strings were unavailable in the extracted dataset for independent code-level verification. These limitations should be considered when interpreting the findings.
5.2. Conclusions
This retrospective single-center study provides a six-year descriptive profile of acute poisoning presentations to the emergency department of Imam Reza Hospital in Tehran. Pharmaceutical agents, particularly benzodiazepines, antidepressants, acetaminophen-related products, and other analgesics, were frequently recorded, and methanol was also a prominent toxic-agent category. Most included patients had documented full or partial recovery, although mortality was recorded in 5.1% of cases. The annual and monthly distributions observed in this cohort should be interpreted as descriptive findings rather than as estimates of incidence or evidence of temporal or seasonal effects. These findings may support local poisoning surveillance, clinical preparedness, and prevention planning; however, confirmation in larger multicenter studies with complete denominator data and standardized information on poisoning intent and co-ingestion is warranted.